BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Tumor protein p63 (TP63; p63); dual specificity phosphatase 6 (DUSP6; MKP3)

October 6, 2016 7:00 AM UTC

Patient sample, cell culture and mouse studies suggest inhibiting TP63 or DUSP6 could help treat p53-mutant cancers. In patients with p53-mutant breast cancer or head and neck squamous cell carcinoma ...